Hepatic Neoplasms
8
1
1
4
Key Insights
Highlights
Success Rate
57% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 90/100
37.5%
3 terminated out of 8 trials
57.1%
-29.4% vs benchmark
13%
1 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (8)
Does a Minimally Invasive Approach to Liver Resection Improve Postoperative Outcomes?
Screening for Synchronous Metastases in Colorectal Cancer With DW-MRI (SERENADE)
Clinical Outcomes of Preoperative and Postoperative Rehabilitation in the Patients With HBP Malignancy
Resection Versus Microwave Ablation for Resectable Colorectal Cancer Liver Metastases
Study of New Software Used During Ablations
Comparative Study on Liver Resection Between Harmonic Scalpel Versus Crush-clamping Method
Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma
Identification of Hepatic Lesions